The Venture Codex Logo

The Venture Codex

Overview

Clinical-stage biopharmaceutical company developing novel cell therapies.

Total Raised

$151 M

Rounds

1

Links

Verticals

Biotechnology
Health Care
Life Science
Oncology
Therapeutics

Investment History

  1. Series A

    Apr 2020

    $151M

Team

Ying Huang

Chief Executive Officer

Alan Bash

President of CARVYKTI

Mythii Koneru

Chief Medical Officer

Lori Macomber

CFO